*001539709
*00520250613111515.0
*007ta
*008130314s1991    ne            000 u eng d
*00901268cam a2200337 c 4500
*019  $bl
*020  $a0444891889$qib.
*035  $a(EXLNZ-47BIBSYS_NETWORK)999619842284702201
*035  $a(NO-LaBS)14155795(bibid)
*035  $a(NO-TrBIB)961984228
*035  $a961984228-47bibsys_network
*040  $aNO-TrBIB$bnob$ekatreg
*060 4$aW1
*060 4$a[QU 85 A629 1991]
*24500$aAntilipidemic drugs :$bmedicinal, chemical and biochemical aspects$c[edited by] D.T. Witiak, H.A.I. Newman, D.R. Feller
*260  $aAmsterdam$bElsevier$c1991
*300  $aXVI, 601 s.$bill.
*4901 $aPharmacochemistry library$vVol. 17
*650 2$aAntilipemic Agents$xchemistry$_82974900
*650 2$aAntilipemic Agents$xtherapeutic use$_82975000
*650 2$aArteriosclerosis$xphysiopathology$_74905700
*650 2$aLipids$xmetabolism$_26484100
*650 2$aLipoproteins$xmetabolism$_70406100
*7001 $aFeller, Dennis R.$0(NO-TrBIB)90956298$_82975100
*7001 $aNewman, Howard A.I.$0(NO-TrBIB)90956297$_82975200
*7001 $aWitiak, Donald T.$0(NO-TrBIB)90282691$_82975300
*830 0$aPharmacochemistry library$vVol. 17$_62340600
*85642$3Forlagets beskrivelse (lang)$uhttps://contents.bibs.aws.unit.no/?isbn=9780444891884
*85642$3Innholdsfortegnelse$uhttps://contents.bibs.aws.unit.no/?isbn=9780444891884
*901  $a80
*999  $aoai:nb.bibsys.no:999619842284702202$b2021-11-14T20:29:17Z$z999619842284702202
^